Literature DB >> 16918883

Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C.

G Borroni1, R Ceriani, M Cazzaniga, M Tommasini, M Roncalli, C Maltempo, C Felline, F Salerno.   

Abstract

BACKGROUND: Biopsy is the gold standard for assessing cirrhosis in patients with chronic hepatitis C virus infection, but it is expensive and at risk of complications. Alternative non-invasive methods have been developed but their usefulness remains uncertain. AIM: To compare the accuracy of five non-invasive scores in detecting cirrhosis.
METHODS: We reviewed the charts and liver biopsies of 228 consecutive, treatment-naïve, hepatitis C virus-positive patients, 13.2% of whom with histological diagnosis of cirrhosis. The five alternative scores were age-platelet index, cirrhosis discriminant score, aspartate transaminases to platelet ratio index, Pohl's index, and aspartate transaminases/alanine transaminases ratio.
RESULTS: The specificities of the scores were good (87-100%), but not so their sensitivities (17-67%). Accordingly positive likelihood ratios were generally good but negative likelihood ratios were suboptimal. Combinations of the scores independently related to cirrhosis only slightly change this diagnostic accuracy. Using double cut-offs to exclude/diagnoses cirrhosis, cirrhosis discriminant score classified 21% of patients without misdiagnoses and aspartate transaminases to platelet ratio index classified 85% of case with 9% of misdiagnoses.
CONCLUSIONS: The five scores showed variable sensitivities and specificities in detecting liver cirrhosis, both individually and in combination. The use of double cut-off points may make the cirrhosis discriminant score and aspartate transaminases to platelet ratio index useful to reduce the number of patients submitted to liver biopsy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918883     DOI: 10.1111/j.1365-2036.2006.03034.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

1.  Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma.

Authors:  Su Jong Yu; Jeong Hoon Lee; Goh Eun Chung; Chang Hoon Lee; Eun Ju Cho; Eun Sun Jang; Min Sun Kwak; Yoon Jun Kim; Jung Hwan Yoon; Ja June Jang; Hyo Suk Lee
Journal:  Korean J Hepatol       Date:  2010-12

2.  Spleen transient elastography predicts actuarial survival after liver transplantation.

Authors:  Kilian Friedrich; Arianeb Mehrabi; Jan Pfeiffenberger; Christian Rupp; Karl Heinz Weiss; Markus Mieth
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

3.  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Amy G Shah; Alison Lydecker; Karen Murray; Brent N Tetri; Melissa J Contos; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-10       Impact factor: 11.382

4.  Quantitative comparison of transient elastography (TE), shear wave elastography (SWE) and liver biopsy results of patients with chronic liver disease.

Authors:  Hyun-Jin Kim; Hae-Kag Lee; Jae-Hwan Cho; Han-Jun Yang
Journal:  J Phys Ther Sci       Date:  2015-08-21

Review 5.  Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection.

Authors:  Sumit Dahal; Smrity Upadhyay; Rashmi Banjade; Prajwal Dhakal; Nabin Khanal; Vijaya Raj Bhatt
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-03-01       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.